Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › indacaterol

indacaterol

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of indacaterol

28 trials tracked of indacaterol: 18 in phase 3 or 4 and 1 with published results. The most-cited published study has 21 citations.

28Trials tracked
18Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 5 Phase 3 13 Phase 2 9 Other / NA 1
  1. Phase 4 Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients Completed · 21 cited
  2. Phase 4 Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD Completed
  3. Phase 4 Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations Completed
  4. Phase 4 Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Completed
  5. Phase 4 Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) Completed
  6. Phase 3 A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control Completed
Show 22 more trials
  1. Phase 3 12-week Open-label Evaluation of Efficacy and Safety of Indacaterol Completed
  2. Phase 3 Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium Completed
  3. Phase 3 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  4. Phase 3 Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  5. Phase 3 Indacaterol EfectIveness In COPD Patients With Tuberculosis History Completed
  6. Phase 3 Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks Completed
  7. Phase 3 Efficacy and Safety of Different Doses of Indacaterol Completed
  8. Phase 3 Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) Completed
  9. Phase 3 Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control Completed
  10. Phase 3 Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Completed
  11. Phase 3 Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Completed
  12. Phase 3 Effect of Indacaterol on Inspiratory Capacity (IC) Completed
  13. Phase 2 Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  14. Phase 2 Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol Completed
  15. Phase 2 Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol Completed
  16. Phase 2 A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma Completed
  17. Phase 2 Dose Ranging Study for Indacaterol in Japanese Asthma Patients Completed
  18. Phase 2 Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Completed
  19. Phase 2 Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Completed
  20. Phase 2 Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma Completed
  21. Phase 2 A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  22. N/A Drug Utilization Study for Olodaterol Completed

Showing the 28 most-cited and recently-updated of 28 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.